Seraph 100 as seen on 60 Minutes
Military Programs Aiming to End Pandemics Forever
Revolutionary
COVID-19 Pathogen Adsorption Therapy
ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter is a revolutionary hemoperfusion medical device that addresses unmet clinical needs in treating bloodstream infections and reducing pathogens. Learn how clinicians are using the Seraph 100 to treat COVID-19.
Better Odds for Patients, Families and Critical Care Teams
The Seraph 100 uses microbead adsorption media with chemically-bonded heparin to mimic the binding sites that pathogens use when they invade the body. Selectively adsorbed pathogens remain bound in the filter.
How Seraph 100 is Saving Lives
Extracorporeal—meaning outside the body—blood purification treatments are usually reserved for the severely or critically ill. Learn more about the role of Seraph 100 in treating COVID-19.
In the News
See what’s happening at ExThera Medical and recent updates about the Seraph 100.
Patient Enrollment is Complete in the DOD-Funded Study of Extracorporeal Hemopurification of Critically Ill COVID-19 Patients
Treatment for critically ill COVID patients results in significant improvement in survival rate according to new study
ExThera Medical and Asahi Kasei Medical Enter into Partnership to Expand Reach of Treatment for the Critically Ill
ExThera and Asahi Kasei Medical secure exclusive distribution agreement in Japan